Table 1.
Clinical and Demographic Characteristics for Patients With Gemcitabine-Related Pneumonitis
| Characteristic | n (%) |
|---|---|
| Age | |
| <50 years | 3 (10) |
| 50–70 years | 12 (42) |
| >70 years | 13 (46) |
| Race | |
| White | 27 (96) |
| Other | 1 (4) |
| Gender | |
| Female | 15 (54) |
| Male | 13 (46) |
| BMI | |
| Normal | 8 (29) |
| Overweight | 15 (54) |
| Obese | 5 (18) |
| History of Lung Disease | |
| COPD | 4 (14) |
| ILD | 2 (7) |
| Asthma | 0 |
| Disease Status | |
| Metastatic | 20 (71) |
| Locally Advanced | 6 (21) |
| Adjuvant | 2 (7) |
| Treatment | |
| Single-agent gemcitabine | 18 (64) |
| Combination therapy | 10 (36) |
| Pneumonitis Grade | |
| 2 | 7 (25) |
| 3 | 18 (64) |
| 4 | 3 (11) |
| Cigarette Smoking | |
| Nonsmoker | 7 (25) |
| Active smoker | 1 (4) |
| Former smoker | 20 (71) |
| Alcohol History | |
| None | 11 (39) |
| Occasional | 11 (39) |
| Regular or heavy | 6 (21) |
Abbreviations: BMI = body mass index; COPD = chronic obstructive pulmonary disease; ILD = interstitial lung disease.